1. Home
  2. Advocacy
  3. Latest News and Practice Data
  4. CDC Issues Alert to Immediately Discard Affected BD BACTEC MGIT 960 PZA Kits

On August 16, the Centers for Disease Control and Prevention (CDC) sent out an alert regarding the removal of affected BD BACTEC™ MGIT™ 960 PZA Kits. The kits may intermittently produce falsely resistant results for pyrazinamide (PZA) during susceptibility testing of Mycobacterium tuberculosis isolates. The current list of affected lots can be found here.

Laboratories should immediately inspect their inventory and destroy affected product subject to the recall following their institution’s process of destruction. There are no recommendations for retesting or reviewing previous patient test results.

BD recall related questions can be sent to: BDRC12@bd.com.

Most Recent Content

  1. CIPI Connections: Pathology Innovation in the Third Dimension
  2. January 23, 2026
  3. House advances bill delaying lab cuts
  4. Utility of Molecular Testing in the Diagnostic Workup of Difficult-to-Classify Tumors
  5. January 20, 2026
  6. View All